BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery]. 1985

I N Boĭko, and V Kh Khavinson, and V G Morozov

UI MeSH Term Description Entries
D008297 Male Males
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D011354 Prodigiozan A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes. Prodigiosan
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004405 Dysentery, Bacillary DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest). Shigellosis,Dysentery, Shiga bacillus,Dysentery, Shigella boydii,Dysentery, Shigella dysenteriae,Dysentery, Shigella dysenteriae type 1,Dysentery, Shigella flexneri,Dysentery, Shigella sonnei,Shigella Dysentery,Shigella Infection,Bacillary Dysentery,Dysenteries, Shigella,Dysenteries, Shigella boydii,Dysenteries, Shigella dysenteriae,Dysenteries, Shigella flexneri,Dysenteries, Shigella sonnei,Dysentery, Shigella,Infection, Shigella,Infections, Shigella,Shiga bacillus Dysentery,Shigella Dysenteries,Shigella Infections,Shigella boydii Dysenteries,Shigella boydii Dysentery,Shigella dysenteriae Dysenteries,Shigella dysenteriae Dysentery,Shigella flexneri Dysenteries,Shigella flexneri Dysentery,Shigella sonnei Dysenteries,Shigella sonnei Dysentery
D005664 Furazolidone A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514) Nifurazolidone,Furazol,Furazolidine,Furoxone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I N Boĭko, and V Kh Khavinson, and V G Morozov
[Effectiveness of prodigiozan in the complex treatment of erysipelas].
August 1984, Klinicheskaia meditsina,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Use of prodigiozan in the complex therapy of dysentery].
April 1973, Vrachebnoe delo,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Effectiveness of administration of thymalin in the complex treatment of pulmonary tuberculosis].
January 1990, Problemy tuberkuleza,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Endolymphatic administration of thymalin in the complex treatment of patients with appendicular peritonitis].
January 1986, Klinicheskaia khirurgiia,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Use of thymalin in the complex treatment of patients with cancer of the uterus].
January 1985, Voprosy onkologii,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
October 1984, Antibiotiki,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Experience with the use of prodigiozan in the complex treatment of patients with pulmonary tuberculosis].
October 1974, Antibiotiki,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Thymalin in the treatment of patients with erysipelas].
July 1987, Klinicheskaia meditsina,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Therapeutic effectiveness of nevigramon in the complex treatment of acute dysentery].
May 1980, Vrachebnoe delo,
I N Boĭko, and V Kh Khavinson, and V G Morozov
[Aminoacrichine in the complex treatment of patients with acute dysentery].
October 1972, Klinicheskaia meditsina,
Copied contents to your clipboard!